{
    "2018-02-09": [
        [
            {
                "time": "2018-02-09",
                "original_text": "干货！2月9日晚间重要公告速读",
                "features": {
                    "keywords": [
                        "公告",
                        "晚间",
                        "重要"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-09",
                "original_text": "多公司发布晚间重要公告 下周走势或将反转",
                "features": {
                    "keywords": [
                        "公告",
                        "晚间",
                        "重要",
                        "走势",
                        "反转"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-09",
                "original_text": "跨境并购、新药申请虽热闹，中国药企的制剂出口2017年表现却平平",
                "features": {
                    "keywords": [
                        "跨境并购",
                        "新药申请",
                        "制剂出口",
                        "中国药企",
                        "2017年",
                        "表现平平"
                    ],
                    "sentiment_score": -0.3,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-02-09",
                "original_text": "2月9日上市公司晚间公告速递",
                "features": {
                    "keywords": [
                        "公告",
                        "晚间",
                        "上市公司"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "综合"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "neutral",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "neutral"
                }
            },
            {
                "time": "2018-02-09",
                "original_text": "复星医药：发行不超50亿元公司债获证监会核准",
                "features": {
                    "keywords": [
                        "复星医药",
                        "发行",
                        "公司债",
                        "证监会",
                        "核准"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-09",
                "original_text": "大摩相信复星医药(02196.HK)股价60日内将升 评级「增持」",
                "features": {
                    "keywords": [
                        "大摩",
                        "复星医药",
                        "股价",
                        "60日",
                        "增持"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-02-09",
                "original_text": "[看好评级]医药生物行业2017年年报业绩前瞻：稳健增长 分化明显 重点关注优质成长与稳健价值",
                "features": {
                    "keywords": [
                        "医药生物",
                        "2017年",
                        "年报",
                        "业绩",
                        "稳健增长",
                        "分化明显",
                        "优质成长",
                        "稳健价值"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}